Biology Department, Nura Bio Inc., South San Francisco, CA 94080, USA.
Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Cell Rep. 2020 Aug 4;32(5):107999. doi: 10.1016/j.celrep.2020.107999.
The NADase SARM1 is a central switch in injury-activated axon degeneration, an early hallmark of many neurological diseases. Here, we present cryo-electron microscopy (cryo-EM) structures of autoinhibited (3.3 Å) and active SARM1 (6.8 Å) and provide mechanistic insight into the tight regulation of SARM1's function by the local metabolic environment. Although both states retain an octameric core, the defining feature of the autoinhibited state is a lock between the autoinhibitory Armadillo/HEAT motif (ARM) and catalytic Toll/interleukin-1 receptor (TIR) domains, which traps SARM1 in an inactive state. Mutations that break this lock activate SARM1, resulting in catastrophic neuronal death. Notably, the mutants cannot be further activated by the endogenous activator nicotinamide mononucleotide (NMN), and active SARM1 is product inhibited by Nicotinamide (NAM), highlighting SARM1's functional dependence on key metabolites in the NAD salvage pathway. Our studies provide a molecular understanding of SARM1's transition from an autoinhibited to an injury-activated state and lay the foundation for future SARM1-based therapies to treat axonopathies.
NAD 酶 SARM1 是损伤激活的轴突退化的中枢开关,这是许多神经退行性疾病的早期标志。在这里,我们呈现了自抑制(3.3Å)和活性 SARM1(6.8Å)的冷冻电子显微镜(cryo-EM)结构,并提供了对 SARM1 功能受局部代谢环境严格调节的机制见解。尽管两种状态都保留了八聚体核心,但自抑制状态的定义特征是自抑制 Armadillo/HEAT 基序(ARM)和催化 Toll/白细胞介素-1 受体(TIR)结构域之间的锁,该锁将 SARM1 锁定在非活性状态。破坏这种锁的突变会激活 SARM1,导致灾难性的神经元死亡。值得注意的是,这些突变体不能被内源性激活剂烟酰胺单核苷酸(NMN)进一步激活,而活性 SARM1 被烟酰胺(NAM)产物抑制,这突出了 SARM1 对 NAD 补救途径中关键代谢物的功能依赖性。我们的研究提供了对 SARM1 从自抑制状态到损伤激活状态转变的分子理解,并为基于 SARM1 的治疗轴突病变的未来疗法奠定了基础。